All the latest articles & insight from our investment writers to inspire your own research and analysis.
Technology and healthcare shares experienced very mixed returns last year. But is it time for investors to change their expectations for these sectors? Ben Hobson explores what might lie ahead. Twelve months of turmoil made 2022 a year to forget for many investors. But one trend that deserves to live long in the memory
The Swiss Central Bank’s balance sheet in 2022 shows signs that Credit Suisse’s problems were well understood, but harder for the authorities to resolve. Companies covered KAPE, SDRY, ALPH and EQLS. The FTSE rose +1% to 7476 in the last five days, most of which was on Monday morning. The Nasdaq100 was up +2% and
Welcome to my first article for SharePad. All being well, this marks the start of a regular column from me exploring ideas, themes and strategies for investing in shares. On the face of it, that sounds like a tall order. I’ve been writing about shares and stock markets for more than 20 years, and one
Shares in kitchen supplier Howden Joinery have rewarded long-term investors handsomely. For me, it is one of the highest quality UK businesses in the FTSE 250 index. It is very shareholder friendly, whilst its annual report is one of the best I have read when it comes to explaining how a business works. Howden has
With the ‘rescue’ of Credit Suisse over the weekend, Bruce ponders what might happen next and which indicators to focus on. Companies covered BUR and TCAP. The FTSE 100 fell -2.5% to 7,358 over the last 5 days. The Nasdaq100 and S&P500 were up +1.4% and 5.8% respectively, indicating that the sell-off in markets has
WANdisco has owned up to ‘significant accounting irregularities’ and the prospects for shareholders now look grim. Maynard Paton revisits the software developer to identify the warning signs Small-Cap Spotlight Report Revisited: WANdisco (LSE: WAND) You can become a better investor by occasionally visiting the stock-market graveyard. One company that now seems destined for the cemetery
Consider Wandisco. It’s a software company that specialises in providing data management and replication services for businesses. The company was founded in 2005 and is headquartered in San Ramon, California, with additional offices in the UK, India, and Poland. Wandisco was listed on the London Stock Exchange’s AIM market in 2012 and has been a
Although Arm will list in the USA, there should be nothing to stop us buying shares in Britain’s top tech company after it floats. This idea leads Richard to a potentially rich seam of investments he has not previously explored: UK firms listed in the USA. Judging by the headlines, news that Arm is to
Following the rescue of Silicon Valley Bank, Bruce looks at possible read across to recent IPOs and IP Group. Companies covered IPO, FRAN and Georgian Banks BGEO / TBCG. I suggested last week that the rally was running out of steam. I was not expecting a bank run in Silicon Valley though (SIVB total assets
Investing in shares is risky but if you want to grow the value of your investments you have to take some risk. Getting the balance between risk and potential returns is one of the key decisions you must make as an investor. There’s often a lot of focus on gains but very little on risk.
With the rally running out of steam, Bruce looks at long-run equity returns. The two banks which compete to publish this data have performed much worse than the average equity. Companies covered SHC, RMV and RCDO. The rally seems to be running out of steam. The FTSE 100 was down -0.2% to 7,917. The Nasdaq
Richard looks at the good and the ugly in Hollywood Bowl’s alternative performance measures and concludes that the company has put a positive gloss on adjusted profit. In Getting to grips with Alternative Performance Measures (APMs), I explained that exceptional items are costs or gains that obscure the underlying performance of a business. This does
